HCM (n = 16) | Controls (n = 14) | p-value | |
---|---|---|---|
Age (y) | 47 ± 14 | 48 ± 15 | 0.82 |
Gender (m/f) | 12/4 | 8/6 | 0.44 |
Mutation in sarcomeric gene | - MYBPC3 (6, 38%) | ||
- MYH7 (1, 6%) | |||
- TNNT2 (2, 13%) | |||
- Excluded (3, 19%) | - Excluded (11, 79%) | ||
- Unknown (4, 25%) | - Unknown (3, 21%) | ||
Systolic BP (mmHg) | 132 ± 12 | 132 ± 26 | 0.96 |
Diastolic BP (mmHg) | 75 ± 11 | 77 ± 9 | 0.67 |
Heart rate (BPM) | 63 ± 13 | 68 ± 10 | 0.21 |
BSA (kg/m2) | 2.0 ± 0.17 | 1.9 ± 0.19 | 0.10 |
Medication | Beta-blocker (8, 50%) | None | |
Ca-antagonist (1, 6%) | |||
Hematocrit (L/L) | 0.45 ± 0.04. | 0.42 ± 0.02 | 0.007 |